Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
page
post
product
Home / Press releases
press_archive_banner

altona Diagnostics announces integration of Velsera’s automated analysis solution into the AltoStar® Molecular Diagnostics Workflow

altona Diagnostics has announced a partnership with Velsera to customize and incorporate Velsera’s AI-based software platform into the AltoStar® Workflow. The integrated solution utilizes Velsera’s FastFinder Analysis, with the resulting solution for automated Real-Time PCR infectious disease testing set to be available to users of the AltoStar® Workflow in the second half of 2023.

Read more »

Assay available for detection of monkeypox virus

Since May 2022 cases of monkeypox have been confirmed in at least 12 countries, that are not endemic for monkeypox virus, e.g. in the USA, Canada, UK, Germany, Spain, and Australia. Due to this development, altona Diagnostics has received more and more requests from all over the world for PCR tests to detect this virus.

Read more »

Regional pilot project started

As part of the pilot project SCoPE (SARS-CoV-2 PCR examination), the feasibility of screening for SARS-CoV-2 using PCR analysis is being tested at two Hamburg day care centers. Day care center children and staff will be screened on a voluntary basis for infections with the SARS-CoV-2 coronavirus. The tests can help to determine the current risk of infection at day care centers and to prevent further infections, e.g. by targeted isolation measures.

Read more »

altona Diagnostics receives CE-IVD mark for HIV RT-PCR test

Hamburg, April 1st, 2021 altona Diagnostics GmbH, today announced the launch of the AltoStar® HIV RT-PCR Kit 1.5, an in vitro diagnostic test, based on real-time RT-PCR technology, for the detection and quantification of human immunodeficiency virus type 1 (HIV-1) specific RNA (groups M, N and O) in human EDTA plasma.

Read more »

altona Diagnostics launches CE-IVD certified RT-PCR test for SARS-CoV-2 detection

Hamburg, April 30th 2020, altona Diagnostics GmbH announced today the launch of the CE-IVD marked RealStar® SARS-CoV-2 RT-PCR Kit 1.0 an in vitro diagnostic test, based on real-time PCR technology, for the qualitative detection of lineage B-beta coronavirus (lineage B-βCoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific RNA. It is intended to be used as an aid for diagnosis in individuals with signs and symptoms of coronavirus disease 2019 (COVID-19) in conjunction with clinical and epidemiological risk factors.

Read more »